New study indicates that. Modern antiretroviral drugs help young people who are infected with the virus can live longer for 10 years
The report was released last Wednesday. Identify 20-year-old HIV-infected people who started taking new antiretroviral drugs in 2010, which is expected to have a 10-year long life expectancy compared to those who started taking ARVs in 1996. Increased use of antiretroviral drugs
Researchers at the University of Bristol in the United Kingdom say that the benefits and advancements that have arisen as a result of new antiretroviral drugs have less impact on user health. And more effective in inhibiting the virus does not give rise to drug resistance. However, the effectiveness of the drug will be much better. Depending on the time that the infected person is infected. And fast stopping drugs.
So the university expects that this research will destroy the old beliefs about health. And life expectancy of HIV infected people. Including improvements in many countries, those who are infected can access treatment more easily. Especially in developing countries. It also campaigns for people at risk to get tested for the virus as soon as possible. For the effectiveness of the drug Just like the World Health Organization has issued advice.
The survey is based on an analysis of 88,500 people in 18 European countries. And North America found that. Fewer deaths have been reported during 2008 - 2010 with new ARVs.Previously, between 1996 and 2013, the average life expectancy of those infected during the 20-year age range was estimated to be 10 years higher for women and 9 years for men, and for additional studies from 2008 to 2010, the average life expectancy of men The new antiretroviral therapy started in the 20-year age range, with an average of 73 years, and 76 years for women.
Over the past 20 years, HIV-infected people who have not been examined by doctors have consistently declined. It is currently believed that 1 in 8 infected people have not yet been tested. For example, a report from the United Nations AIDS Program in 2015 had an estimated 37 million people living with HIV, of whom 17 had access to antiretrovirals. Of these, most are infected by syringes. This is a risk group that can not access health insurance.